Kymera Therapeutics, Inc. SEC filings KYMR

Kymera Therapeutics, Inc. has 647 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Kymera Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Oct 1, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 8, 2026 —
4 Insider transaction Sep 4, 2026 Sep 4, 2026
144 Notice of proposed sale Sep 4, 2026 —
144 Notice of proposed sale Sep 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Jul 27, 2026 Jul 27, 2026
3 Initial insider ownership Jul 27, 2026 Jul 27, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 27, 2026 Jul 27, 2026
4 Insider transaction Jul 7, 2026 Jul 7, 2026
144 Notice of proposed sale Jul 7, 2026 —
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
4/A Filing Jul 2, 2026 Jun 26, 2026
144 Notice of proposed sale Jul 2, 2026 —
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 30, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 30, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
4 Insider transaction Jun 26, 2026 Jun 26, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
144 Notice of proposed sale Jun 26, 2026 —
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 25, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 25, 2026 —
144 Notice of proposed sale Jun 25, 2026 —
4 Insider transaction Jun 25, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 25, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 25, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 24, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
8-K Current report
Shareholder vote results
Jun 24, 2026 Jun 24, 2026
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 18, 2026 —
144 Notice of proposed sale Jun 18, 2026 —
144 Notice of proposed sale Jun 17, 2026 —
144 Notice of proposed sale Jun 17, 2026 —
144 Notice of proposed sale Jun 17, 2026 —
144 Notice of proposed sale Jun 17, 2026 —
8-K Current report
Officer or director change
Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 3, 2026 Jun 2, 2026
4 Insider transaction May 27, 2026 May 26, 2026
144 Notice of proposed sale May 26, 2026 —
144 Notice of proposed sale May 26, 2026 —
4 Insider transaction May 19, 2026 May 19, 2026
4 Insider transaction May 19, 2026 May 18, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 11, 2026 May 11, 2026
144 Notice of proposed sale May 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
4 Insider transaction Apr 29, 2026 Apr 29, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 29, 2026 —
144 Notice of proposed sale Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 24, 2026
4 Insider transaction Apr 24, 2026 Apr 22, 2026
4 Insider transaction Apr 24, 2026 Apr 22, 2026
144 Notice of proposed sale Apr 22, 2026 —
144 Notice of proposed sale Apr 22, 2026 —
144 Notice of proposed sale Apr 22, 2026 —
4 Insider transaction Apr 16, 2026 Apr 14, 2026
4 Insider transaction Apr 16, 2026 Apr 14, 2026
4 Insider transaction Apr 16, 2026 Apr 14, 2026
144 Notice of proposed sale Apr 15, 2026 —
144 Notice of proposed sale Apr 15, 2026 —
144 Notice of proposed sale Apr 15, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
144 Notice of proposed sale Apr 14, 2026 —
4 Insider transaction Apr 10, 2026 Apr 9, 2026
144 Notice of proposed sale Apr 9, 2026 —
4 Insider transaction Apr 1, 2026 Mar 31, 2026
4 Insider transaction Apr 1, 2026 Mar 31, 2026
144 Notice of proposed sale Apr 1, 2026 —
144 Notice of proposed sale Apr 1, 2026 —
144 Notice of proposed sale Mar 31, 2026 —
144 Notice of proposed sale Mar 31, 2026 —
8-K Current report
Bylaw or fiscal year change
Mar 27, 2026 Mar 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 25, 2026 Mar 23, 2026
144 Notice of proposed sale Mar 23, 2026 —
4 Insider transaction Mar 20, 2026 Mar 20, 2026
144 Notice of proposed sale Mar 20, 2026 —
4 Insider transaction Mar 11, 2026 Mar 11, 2026
144 Notice of proposed sale Mar 11, 2026 —
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
8-K Current report
Material agreement, Agreement ended, Other events
Feb 26, 2026 Feb 26, 2026
424B3 Prospectus Feb 26, 2026 —
424B5 Prospectus supplement Feb 26, 2026 —
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
4 Insider transaction Feb 25, 2026 Feb 25, 2026
144 Notice of proposed sale Feb 25, 2026 —
4 Insider transaction Feb 20, 2026 Feb 20, 2026
144 Notice of proposed sale Feb 20, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
4 Insider transaction Jan 20, 2026 Jan 20, 2026
144 Notice of proposed sale Jan 20, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2026 Jan 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 8, 2026 —
4 Insider transaction Jan 6, 2026 Jan 5, 2026
4 Insider transaction Dec 31, 2025 Dec 31, 2025
144 Notice of proposed sale Dec 31, 2025 —
4 Insider transaction Dec 17, 2025 Dec 17, 2025
4 Insider transaction Dec 17, 2025 Dec 17, 2025
144 Notice of proposed sale Dec 17, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 15, 2025 —
4 Insider transaction Dec 12, 2025 Dec 10, 2025
144 Notice of proposed sale Dec 12, 2025 —
144 Notice of proposed sale Dec 12, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 11, 2025 —
144 Notice of proposed sale Dec 11, 2025 —
144 Notice of proposed sale Dec 11, 2025 —
4 Insider transaction Dec 11, 2025 Dec 11, 2025
144 Notice of proposed sale Dec 10, 2025 —
144 Notice of proposed sale Dec 10, 2025 —
8-K Current report
Material agreement, Other events
Dec 10, 2025 Dec 8, 2025
424B5 Prospectus supplement Dec 10, 2025 —
4 Insider transaction Dec 8, 2025 Dec 8, 2025
4 Insider transaction Dec 8, 2025 Dec 8, 2025
4 Insider transaction Dec 8, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 8, 2025 —
144 Notice of proposed sale Dec 8, 2025 —
144 Notice of proposed sale Dec 8, 2025 —
424B5 Prospectus supplement Dec 8, 2025 —
8-K Current report
Regulation FD disclosure
Dec 8, 2025 Dec 8, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2025 Dec 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
4 Insider transaction Oct 29, 2025 Oct 29, 2025
144 Notice of proposed sale Oct 29, 2025 —
4 Insider transaction Oct 15, 2025 Oct 15, 2025
144 Notice of proposed sale Oct 15, 2025 —
4 Insider transaction Oct 14, 2025 Oct 13, 2025
4 Insider transaction Oct 14, 2025 Oct 13, 2025
144 Notice of proposed sale Oct 14, 2025 —
144 Notice of proposed sale Oct 14, 2025 —
4 Insider transaction Sep 17, 2025 Sep 17, 2025
144 Notice of proposed sale Sep 17, 2025 —
4 Insider transaction Sep 16, 2025 Sep 16, 2025
144 Notice of proposed sale Sep 16, 2025 —
4 Insider transaction Sep 3, 2025 Sep 3, 2025
3 Initial insider ownership Sep 3, 2025 Sep 3, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 3, 2025 Aug 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jul 1, 2025 Jun 25, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 30, 2025 —
4 Insider transaction Jun 30, 2025 Jun 30, 2025
8-K Current report
Material agreement, Other events
Jun 27, 2025 Jun 25, 2025
8-K Current report
Shareholder vote results
Jun 27, 2025 Jun 25, 2025
424B5 Prospectus supplement Jun 27, 2025 —
4 Insider transaction Jun 26, 2025 Jun 25, 2025
4 Insider transaction Jun 26, 2025 Jun 25, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
KYMR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Watertown, MA
SEC filer status
Large accelerated filer
SEC CIK
1815442
Former names
Kymera Therapeutics, Inc. (until Oct 29, 2026)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.